Inclusion Criteria:

- Males or non-pregnant females currently receiving or post radiation therapy for head
and neck cancer;

- 18 years of age;

- With signs and symptoms of oral candidiasis as determined by investigator(s);

- Females using an effective contraception method during study.

- Patients must be able and willing to comply with study requirements, and have full
understanding of all elements of, and signature and dating of, informed consent prior
to initiation of protocol specified procedures.

- Participating female subjects must agree to use adequate contraceptive measures
during the trial. Before entering the study, women of childbearing age will be
tested for pregnancy with a urine pregnancy test.

Exclusion Criteria:

- History, or current evidence, of any significant acute or chronic medical or
psychiatric condition that would render examination difficult or invalid or prevent
the subject from active study participation;

- Inability to use an oral rinse;

- Use of concomitant medication that, in the opinion of the Study Director, might
interfere with the outcome of the study (e.g. anabolic steroids or excessive
corticosteroids, large doses of aspirin (no more than one 325 mg tablet per day),
phenytoin, lithium, coumadin or Iodine containing preparations [use of iodized table
salt is acceptable]). Steroids, therapeutic doses of non-steroidal anti-inflammatory
agents, estrogen therapy agents and oral contraceptives are OK to use as long as the
baseline dose remains steady through the end of the study;

- Use of antifungal medication in the last 30 days, purported sensitivity or allergy to
iodine;

- Pregnant or nursing patients as the effect of Iocide in the fetus or infant are not
established;

- History thyroid disease.